CoronaryImpact of Periprocedural Myocardial Biomarker Elevation on Mortality Following Elective Percutaneous Coronary Intervention
Under an Elsevier user license
open archive
Central Illustration
Key Words
cardiac troponin
CK-MB
drug-eluting stent
percutaneous coronary intervention
mortality
Abbreviations and Acronyms
CK-MB
creatine kinase–myocardial band
cTn
cardiac troponin
DES
drug-eluting stent(s)
MI
myocardial infarction
PCI
percutaneous coronary intervention
SCAI
Society for Cardiovascular Angiography and Interventions
ULN
upper limit of normal
Cited by (0)
This work was supported by Cardialysis. Dr. von Birgelen has received institutional research grants from Biotronik, Boston Scientific, and Medtronic. Dr. Steg has received research grants from Bayer, Merck, Sanofi, and Servier; and has received speaking or consulting fees from Amarin, Amgen, AstraZeneca, Bayer/Janssen, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, Merck Novartis, Pfizer, Regeneron, Sanofi, and Servier. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
© 2019 by the American College of Cardiology Foundation. Published by Elsevier.